Gary J. Grover

723 total citations
28 papers, 600 citations indexed

About

Gary J. Grover is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gary J. Grover has authored 28 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 13 papers in Cardiology and Cardiovascular Medicine and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gary J. Grover's work include Cardiac Ischemia and Reperfusion (20 papers), Cardiac Imaging and Diagnostics (9 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Gary J. Grover is often cited by papers focused on Cardiac Ischemia and Reperfusion (20 papers), Cardiac Imaging and Diagnostics (9 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Gary J. Grover collaborates with scholars based in United States, Sweden and Germany. Gary J. Grover's co-authors include Keith Garlid, William A. Schumacher, Carol A. Sargent, Martin L. Ogletree, Charles S. Parham, Paul G. Sleph, Steven Dzwonczyk, Harvey R. Weiss, Michael J. Antonaccio and Diane E. Normandin and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Pharmacology and Experimental Therapeutics and Cardiovascular Research.

In The Last Decade

Gary J. Grover

28 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary J. Grover United States	11	401	262	210	187	93	28	600
Masato Tani Japan	11	348 0.9×	310 1.2×	257 1.2×	141 0.8×	94 1.0×	20	659
Tsuneo Mizumura United States	10	420 1.0×	183 0.7×	129 0.6×	260 1.4×	146 1.6×	14	565
Srinivasan G. Varadarajan United States	12	535 1.3×	229 0.9×	311 1.5×	265 1.4×	202 2.2×	15	728
J INSERTE Spain	9	434 1.1×	269 1.0×	351 1.7×	196 1.0×	63 0.7×	13	711
Yuki Ohmoto‐Sekine Japan	9	530 1.3×	316 1.2×	228 1.1×	222 1.2×	130 1.4×	17	789
M Tani Japan	11	662 1.7×	588 2.2×	362 1.7×	252 1.3×	77 0.8×	23	1.0k
S Isomoto Japan	5	269 0.7×	203 0.8×	190 0.9×	85 0.5×	49 0.5×	9	463
Yoshito Ohnuma Japan	7	289 0.7×	109 0.4×	166 0.8×	153 0.8×	87 0.9×	8	391
Joanne E. Parker United Kingdom	8	401 1.0×	86 0.3×	386 1.8×	145 0.8×	124 1.3×	9	657
Nagammal Venkatesh United States	13	306 0.8×	618 2.4×	389 1.9×	138 0.7×	26 0.3×	20	818

Countries citing papers authored by Gary J. Grover

Since Specialization

Citations

This map shows the geographic impact of Gary J. Grover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary J. Grover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary J. Grover more than expected).

Fields of papers citing papers by Gary J. Grover

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary J. Grover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary J. Grover. The network helps show where Gary J. Grover may publish in the future.

Co-authorship network of co-authors of Gary J. Grover

This figure shows the co-authorship network connecting the top 25 collaborators of Gary J. Grover. A scholar is included among the top collaborators of Gary J. Grover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary J. Grover. Gary J. Grover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grover, Gary J. & Keith Garlid. (2000). ATP-Sensitive Potassium Channels: A Review of their Cardioprotective Pharmacology. Journal of Molecular and Cellular Cardiology. 32(4). 677–695. 322 indexed citations

DʼAlonzo, Albert J., Jia L. Zhu, Raymond B. Darbenzio, Charles R. Dorso, & Gary J. Grover. (1998). Proarrhythmic Effects of Pinacidil are Partially Mediated Through Enhancement of Catecholamine Release in Isolated Perfused Guinea-pig Hearts. Journal of Molecular and Cellular Cardiology. 30(2). 415–423. 21 indexed citations

Gomoll, Allen W., et al.. (1997). Effect of Timing of Treatment of the Glyburide-Reversible Cardioprotective Activity of BMS-180448. Journal of Pharmacology and Experimental Therapeutics. 281(1). 24–33. 7 indexed citations

Monticello, Thomas M., et al.. (1996). Amelioration of ischemia/reperfusion injury in isolated rat hearts by the ATP-sensitive potassium channel opener BMS-180448. Cardiovascular Research. 31(1). 93–101. 18 indexed citations

Grover, Gary J., Charles S. Parham, Daisy B. Whigan, & James Mitroka. (1996). BMS-180448, a novel glyburide-reversible cardioprotective agent, enhances postischemic recovery of contractile function in dogs.. Journal of Pharmacology and Experimental Therapeutics. 276(2). 380–387. 5 indexed citations

Gomoll, Allen W., Gary J. Grover, & Martin L. Ogletree. (1994). Myocardial Salvage Efficacy of the Thromboxane Receptor Antagonist Ifetroban in Ferrets and Dogs. Journal of Cardiovascular Pharmacology. 24(6). 960–968. 8 indexed citations

Grover, Gary J., William A. Schumacher, & Martin L. Ogletree. (1994). Thromboxane Receptor Antagonist BMS-180291, but Not Aspirin, Reduces the Severity of Pacing-Induced Ischemia in Dogs. Journal of Cardiovascular Pharmacology. 24(3). 493–499. 26 indexed citations

Sargent, Carol A., Steven Dzwonczyk, & Gary J. Grover. (1994). The effect of α2-adrenoceptor antagonists in isolated globally ischemic rat hearts. European Journal of Pharmacology. 261(1-2). 25–32. 6 indexed citations

Sargent, Carol A., Paul G. Sleph, Steven Dzwonczyk, et al.. (1993). Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channel.. Journal of Pharmacology and Experimental Therapeutics. 265(2). 609–618. 24 indexed citations

10.

Sargent, Carol A., O. Vesterqvist, Martin L. Ogletree, & Gary J. Grover. (1993). Effects of Endogenous and Exogenous Lysophosphatidylcholine in Isolated Perfused Rat Hearts. Journal of Molecular and Cellular Cardiology. 25(8). 905–913. 19 indexed citations

11.

Grover, Gary J., Carol A. Sargent, Steven Dzwonczyk, Diane E. Normandin, & Michael J. Antonaccio. (1993). Protective Effect of Serotonin (5-HT2) Receptor Antagonists in Ischemic Rat Hearts. Journal of Cardiovascular Pharmacology. 22(4). 664–664. 20 indexed citations

12.

González-Lavin, Lorenzo, et al.. (1991). Thromboxane A2 receptor blockade improves contractile function following cardiopulmonary bypass in dogs and pigs. Journal of Surgical Research. 51(4). 336–340. 4 indexed citations

13.

Grover, Gary J., Charles S. Parham, & William A. Schumacher. (1991). The combined antiischemic effects of the thromboxane receptor antagonist SQ 30,741 and tissue-type plasminogen activator. American Heart Journal. 121(2). 426–433. 3 indexed citations

14.

Moreland, Suzanne, Lisa M. Antes, Diane M. McMullen, Paul G. Sleph, & Gary J. Grover. (1990). Myosin light-chain phosphorylation and vascular resistance in canine anterior tibial arteries in situ. Pflügers Archiv - European Journal of Physiology. 417(2). 180–184. 3 indexed citations

15.

Schumacher, William A. & Gary J. Grover. (1990). The thromboxane receptor antagonist SQ 30,741 reduces myocardial infarct size in monkeys when given during reperfusion at a threshold dose for improving reflow during thrombolysis. Journal of the American College of Cardiology. 15(4). 883–889. 10 indexed citations

16.

Grover, Gary J., Charles S. Parham, Paul G. Sleph, & Suzanne Moreland. (1989). Anti-ischemic and vasorelaxant effects of the new benzazepine calcium channel blocker SQ 31,765.. Journal of Pharmacology and Experimental Therapeutics. 251(3). 1020–1025. 3 indexed citations

17.

Grover, Gary J., et al.. (1988). Propranolol and thyroxine-induced hypertrophic rabbit hearts: Effect on heart size and regional O2 supply/consumption variables. Basic Research in Cardiology. 83(3). 268–276. 2 indexed citations

18.

Grover, Gary J., Paul G. Sleph, & Charles S. Parham. (1988). The Role of Thromboxane A2 in Reperfusion Injury. Experimental Biology and Medicine. 188(4). 504–508. 14 indexed citations

19.

Grover, Gary J., William A. Schumacher, Michael S. Simon, & Charles S. Parham. (1988). The Effect of the Thromboxane A2/Prostaglandin Endoperoxide Receptor Antagonist SQ 30,741 on Myocardial Infarct Size and Blood Flow During Myocardial Ischemia and Reperfusion. Journal of Cardiovascular Pharmacology. 12(6). 701–709. 14 indexed citations

20.

Grover, Gary J. & William A. Schumacher. (1988). Effect of the Thromboxane Receptor Antagonist SQ 29,548 on Myocardial Infarct Size in Dogs. Journal of Cardiovascular Pharmacology. 11(1). 29–35. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact